Real-world study for clinical Outcomes of Paroxysmal Atrial Fibrillation Ablation Using ThermoCool SmartTouch Catheter Technology

Single Transseptal Puncture Technique and Contact Force Sensing Ablation Strategy for Paroxysmal Atrial Fibrillation in Real-world

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033663

Enrollment

Unknown

Registered

2020-06-08

Start date

2014-09-01

Completion date

Unknown

Last updated

2020-06-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

atrial fibrillation

Interventions

Case series:radiofrequency ablation

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Patients with non-valvular, antiarrhythmic drug refractory PAF who underwent de novo RFCA in Fuwai Hospitalyanj are enrolled.

Exclusion criteria

Exclusion criteria: The patients who had previous AF ablation history, LA size > 55mm measured on echocardiogram, documented LA thrombus, severe pulmonary diseases, or previous cardiac surgical history are excluded.

Design outcomes

Primary

Measure	Time frame
recurrence;complication;	—

Countries

China

Contacts

Public ContactYao Yan

Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

ianyao@263.net.cn+86 13901121319

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026